- Home
- ARTW vs BFRI Comparison
ARTW vs BFRI Comparison
Compare ARTW & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARTW
- BFRI
- Stock Information
- Founded
- ARTW 1956
- BFRI 1997
- Country
- ARTW United States
- BFRI United States
- Employees
- ARTW N/A
- BFRI N/A
- Industry
- ARTW Industrial Machinery/Components
- BFRI Biotechnology: Pharmaceutical Preparations
- Sector
- ARTW Industrials
- BFRI Health Care
- Exchange
- ARTW Nasdaq
- BFRI Nasdaq
- Market Cap
- ARTW 8.7M
- BFRI 8.7M
- IPO Year
- ARTW N/A
- BFRI 2021
- Fundamental
- Price
- ARTW $1.50
- BFRI $0.73
- Analyst Decision
- ARTW
- BFRI Strong Buy
- Analyst Count
- ARTW 0
- BFRI 1
- Target Price
- ARTW N/A
- BFRI $7.00
- AVG Volume (30 Days)
- ARTW 13.4K
- BFRI 89.8K
- Earning Date
- ARTW 04-11-2025
- BFRI 03-21-2025
- Dividend Yield
- ARTW N/A
- BFRI N/A
- EPS Growth
- ARTW 17.02
- BFRI N/A
- EPS
- ARTW 0.06
- BFRI N/A
- Revenue
- ARTW $24,499,371.00
- BFRI $37,321,000.00
- Revenue This Year
- ARTW N/A
- BFRI $28.62
- Revenue Next Year
- ARTW N/A
- BFRI $27.07
- P/E Ratio
- ARTW $26.13
- BFRI N/A
- Revenue Growth
- ARTW N/A
- BFRI 9.54
- 52 Week Low
- ARTW $1.33
- BFRI $0.65
- 52 Week High
- ARTW $4.15
- BFRI $2.43
- Technical
- Relative Strength Index (RSI)
- ARTW 31.94
- BFRI 29.58
- Support Level
- ARTW $1.51
- BFRI $0.77
- Resistance Level
- ARTW $1.64
- BFRI $0.96
- Average True Range (ATR)
- ARTW 0.07
- BFRI 0.08
- MACD
- ARTW -0.02
- BFRI -0.01
- Stochastic Oscillator
- ARTW 0.00
- BFRI 8.15
About ARTW Art's-Way Manufacturing Co. Inc.
Art's-Way Manufacturing Co Inc is a manufacturer of agricultural equipment. It has two reportable segments: Agricultural Products, and Modular Buildings. The Agricultural Products segment fabricates and sells farming products as well as related equipment and replacement parts for these products in the United States and world wide. Its Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses. It derives revenues from the Agricultural Products segment.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. Its licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. Its licensed product is Ameluz, which is a prescription drug approved for use in combination with the RhodoLED lamp series, for PDT (when used together, Ameluz PDT). including the complementary product BF-RhodoLED, and Xepi.